On October 23rd, a reporter learned from Kingmed Diagnostics that the cancer pathology gene large model DeepGEM has recently been deployed at the company. Relying on this large model, the company will jointly develop a pathological gene multimodal large model with Tencent and the First Affiliated Hospital of Guangzhou Medical University, allowing accurate, timely, and accessible gene mutation prediction new technology to benefit more cancer patients. (Science and Technology Daily)